Patents-Review.com
ClassID:

20165 ⎘

A61K9/5107 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Nanocapsules Excipients; Inactive ingredients

Sub-classes:
Recent Application in this class:
#1
20260007766
2026-01-08

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

 #2
20250205271
2025-06-26

MICRORNAS FOR INHIBITING THE EXPRESSION OF TRF2 IN TUMORS

 #3
20250195676
2025-06-19

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

 #4
20240238239
2024-07-18

METHODS AND COMPOSITIONS FOR POTENTIATING STEM CELL THERAPIES

 #5
20230201363
2023-06-29

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #6
20230201362
2023-06-29

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #7
20230047754
2023-02-16

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

 #8
20220370488
2022-11-24

MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE THEREOF ENHANCING IMMUNE RESPONSE

 #9
20220340933
2022-10-27

NANOPARTICLE COMPOSITIONS FOR GENE THERAPY

 #10
20220257767
2022-08-18

IONIC LIQUIDS FOR DRUG DELIVERY

 #11
20220133900
2022-05-05

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #12
20220096647
2022-03-31

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

 #13
20220062434
2022-03-03

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #14
20220040323
2022-02-10

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #15
20220040322
2022-02-10

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #16
20220008550
2022-01-13

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #17
20210187116
2021-06-24

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #18
20200405877
2020-12-31

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #19
20200146995
2020-05-14

MAGNETIC NANOPARTICLES FOR TARGETED DELIVERY

 #20
20190388559
2019-12-26

ENCAPSULATION OF METAL OXIDE NANOMATERIALS FOR CONTROLLED RELEASE AND TARGETED DELIVERY

 #21
20190298847
2019-10-03

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #22
20190269646
2019-09-05

Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases

 #23
20190111064
2019-04-18

STATIN + VITAMIN D COMBINATION DRUG AND METHOD OF USE

 #24
20170165289
2017-06-15

Methods and compositions for treating malignant tumors associated with kras mutation

 #25
20170100603
2017-04-13

Mixture of lafesih magnetic nanoparticles with different curie temperatures for improved inductive heating efficiency for hyperthermia therapy

 #26
20170042826
2017-02-16

Nanolipidic particle assembly populations

 #27
20160331696
2016-11-17

Oxygenated Antimicrobial Topical Composition and Process for Making Same

 #28
20160319280
2016-11-03

Multilayered nanoparticle and methods of manufacturing and using the same

 #29
20160245759
2016-08-25

Pharmaceutical dosage forms fabricated with nanomaterials

 #30
20160008316
2016-01-14

USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES

 #31
20150157713
2015-06-11

Method and composition for hyperthermally treating cells

 #32
20150044299
2015-02-12

Oxygenated antimicrobial topical composition

 #33
20140294981
2014-10-02

Carbon encapsulated transition metal oxide nanocomposite, a method for its preparation and its use in li-ion batteries

 #34
20140170227
2014-06-19

Method for making nanolipidic particles

 #35
20140170226
2014-06-19

Method for making nanolipidic particles

 #36
20140079776
2014-03-20

Nanostructures for drug delivery

 #37
20140072639
2014-03-13

Nanolipidic particle assembly populations

 #38
20140023703
2014-01-23

Nanocapsules with a polymer shell

 #39
20120195940
2012-08-02

Nanolipidic particles

 #40
20120114706
2012-05-10

Endorphin Therapy Compositions and Methods of Use Thereof

 #41
20120076730
2012-03-29

Peptides for transport of therapeutics and their carriers in mouse models and humans

 #42
20110300219
2011-12-08

Nanostructures for drug delivery

 #43
20100239686
2010-09-23

Method for making nanolipidic particles

 #44
20090004231
2009-01-01

Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring

 #45
20070154539
2007-07-05

Nanolipidic particles